Abstract
The presence of medical illnesses among inpatients with bipolar disorder is known to complicate treatment and lengthen hospital stay. However, except for a few specific diseases, little is known about prevalence of medical illnesses in bipolar outpatients and the effect it may have on treatment. The authors sought to assess the presence of medical illnesses in a large outpatient clinical sample of bipolar patients, and the effect that medical illnesses may have on the clinical assessment and treatment of the underlying bipolar disorder. Using the Duke University Medical Center clinical database, the authors categorized the medical diagnoses of 1379 patients who were treated with bipolar disorder from 2001 to 2002 through outpatient psychiatric clinics. The prevalence of medical comorbidities was examined, as well as the effect their presence had on the clinician's assessment of disease severity and time to improvement. As expected, medical comorbidities increased with age. The most common systemic illnesses in bipolar outpatients were Endocrine and Metabolic Diseases (13.6% of the sample), Diseases of the Circulatory System (13.0%), and Diseases of the Nervous System and Sense Organs (10.7%). Significant specific diseases included cardiovascular diseases/hypertension (10.7%), COPD/asthma (6.1%), diabetes (4.3%), HIV infection (2.8%), and hepatitis C infection (1.9%). Clinicians assessed greater severity of illness in patients with increasing numbers of comorbid conditions; however, the time to recovery was not significantly effected by the presence of medical comorbidity. In conclusion, comorbid medical illnesses are common in bipolar outpatients, increasing with age. HIV rates may be increased relative to population norms. Their presence compounds the severity of the illness at time of presentation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
American Psychiatry Association (2002). Practice guidelines for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159 (April Suppl): 1–50.
Black DW, Hulbert J, Nasrallah A (1989). The effect of somatic treatment and comorbidity on immediate outcome in manic patients. Compr Psychiatry 30: 74–79.
Black DW, Winokur G, Bell S, Nasrallah A, Hulbert J (1998a). Complicated mania: comorbidity and immediate outcome in the treatment of mania. Arch Gen Psychiatry 45: 232–236.
Black DW, Winokur G, Hulbert J, Nasrallah A (1998b). Predictors of immediate response in the treatment of mania: the importance of comorbidity. Biol Psychiatry 24: 191–198.
Cassidy F, Ahearn E, Carroll J (1999). Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 156: 1417–1420.
Cassidy F, Carroll BJ (2002). Vascular risk factors in late onset mania. Psychol Med 32: 359–362.
Center for Disease Control 1980–2000. Diabetes surveillance system: prevalence of diabetes, 1980–2000. www.cdc.gov/diabetes/statistics/prev/national/fig2.htm.
Cradock-O'Leary J, Young AS, Yano EM, Wang M, Lee ML (2002). Use of General medical services by VA patients with psychiatric disorders. Psychiatr Serv 53: 874–878.
Ewald H, Mortensen PB, Mors O (2001). Decreased risk of acute appendicitis in patients with schizophrenia of manic-depressive psychosis. Schiz Res 49: 287–293.
Fasmer OB (2001). The prevalence of migraine in patients with bipolar and unipolar affective disorders. Cephalgia 21: 894–899.
Mahmood T, Romans S, Silverstone T (1999). Prevalence of migraine in bipolar disorder. J Aff Disord 52: 239–241.
McIntyre RS, Mancini DA, McCann S, Srinivasan J, Kennedy SH (2003). Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord 5: 28–35.
Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV (2002). Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I and schizoaffective disorders independent of psychotropic drug use. J Aff Disord 70: 19–26.
Strakowski SM, Tohen M, Stoll AL, Faedda GL, Mayer PV, Kolbrener ML et al (1992). Comorbidity in mania at first hospitalization. Am J Psychiatry 149: 554–556.
Winokur G, Coryell W, Endicott J, Akiskal H (1993). Further distinctions between manic-depressive illness and primary depressive disorder. Am J Psychiatry 150: 1176–1181.
World Health Organization (1996). International Classification of Diseases, 9th Revision, Clinical Modification, 5th edn. (ICD-9-CM). Practice Management Information Corporation: Los Angeles, CA.
Acknowledgements
Support for this research has been provided by NIMH grant #R01-MH57027 and NARSAD. We also acknowledge Laura Taylor, MS for her assistance with the clinical data information set.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beyer, J., Kuchibhatla, M., Gersing, K. et al. Medical Comorbidity in a Bipolar Outpatient Clinical Population. Neuropsychopharmacol 30, 401–404 (2005). https://doi.org/10.1038/sj.npp.1300608
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300608
Keywords
This article is cited by
-
The prevalence and clinical correlates of medical disorders comorbidities in patients with bipolar disorder
BMC Psychiatry (2022)
-
Telomere Length and Bipolar Disorder
Neuropsychopharmacology (2018)
-
Genetic pleiotropy between mood disorders, metabolic, and endocrine traits in a multigenerational pedigree
Translational Psychiatry (2018)
-
HIV-Infected Individuals with Co-occurring Bipolar Disorder Evidence Poor Antiretroviral and Psychiatric Medication Adherence
AIDS and Behavior (2012)
-
An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses
European Archives of Psychiatry and Clinical Neuroscience (2011)
